Insider Trading activities of Kezar Life Sciences, Inc. (KZR)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Kezar Life Sciences, Inc. (KZR) since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Kezar Life Sciences, Inc. since year 2005. Table 2 shows the detailed insider transactions of Kezar Life Sciences, Inc. since 2005. The reporting company's ticker symbol is KZR. The reporting company's CIK number is 1645666.
The total value of stock buying since 2005 is $21,033,468.
The total value of stock sales since 2005 is $0.
The total value of stock option exercises since 2005 is $45,000.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Kezar Life Sciences, Inc. (KZR).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2020-02 4,018,921 $10,449,192 0 $0 0 $0
2019-12 0 $0 0 $0 50,000 $45,000
2019-11 800 $2,207 0 $0 0 $0
2019-10 1,000 $3,235 0 $0 0 $0
2019-08 15,320 $73,492 0 $0 0 $0
2019-07 931 $5,342 0 $0 0 $0
2018-06 700,000 $10,500,000 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Kezar Life Sciences, Inc. insiders (KZR)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2020-02-04 Economides Vassiliki (SVP, Strategy & External Aff.) Buy 5,769 2.60 14,999
2020-02-04 Fowler John Franklin (CEO) Buy 38,461 2.60 99,998
2020-02-04 Kirk Christopher J. (President and CSO) Buy 38,461 2.60 99,998
2020-02-04 Morningside Venture Investments Ltd (10% Owner) Buy 3,800,000 2.60 9,880,000
2020-02-04 Belsky Marc (CFO) Buy 15,384 2.60 39,998
2020-02-04 Berger Franklin M (Director) Buy 120,846 2.60 314,199
2019-12-19 Fowler John Franklin (CEO) Option Ex 50,000 .90 45,000
2019-11-13 Belsky Marc (CFO) Buy 800 2.76 2,207
2019-10-10 Fowler John Franklin (CEO) Buy 1,000 3.23 3,235
2019-08-20 Economides Vassiliki (SVP, Strategy & External Aff.) Buy 350 4.41 1,543
2019-08-20 Belsky Marc (CFO) Buy 200 4.42 884
2019-08-13 Fowler John Franklin (CEO) Buy 2,000 4.66 9,310
2019-08-13 Kirk Christopher J. (President and CSO) Buy 5,000 4.61 23,040
2019-08-09 Economides Vassiliki (SVP, Strategy & External Aff.) Buy 1,020 4.96 5,057
2019-08-09 Fowler John Franklin (CEO) Buy 1,250 5.13 6,418
2019-08-09 Kirk Christopher J. (President and CSO) Buy 5,000 4.97 24,830
2019-08-09 Belsky Marc (CFO) Buy 500 4.82 2,410
2019-07-26 Belsky Marc (CFO) Buy 56 5.80 324
2019-07-25 Belsky Marc (CFO) Buy 444 5.65 2,510
2019-07-22 Economides Vassiliki (SVP, Strategy & External Aff.) Buy 431 5.82 2,508
2018-06-25 Cormorant Global Healthcare Master Fund, Lp Buy 250,000 15.00 3,750,000
2018-06-25 Morningside Venture Investments Ltd (10% Owner) Buy 250,000 15.00 3,750,000
2018-06-25 Bay City Capital Llc Buy 150,000 15.00 2,250,000
2018-06-25 Berger Franklin M (Director) Buy 50,000 15.00 750,000

Insider trading activities including stock purchases, stock sales, and option exercises of KZR listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Kezar Life Sciences, Inc. (symbol KZR, CIK number 1645666) see the Securities and Exchange Commission (SEC) website.




Real-time Insider Trading

Insider Officer Cluster Trading

Top Officer Buys of the Week

Top Officer Buys of the Month